tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ATRA Stock Latest News

ATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1d ago
ATRA
Atara Biotherapeutics price target raised to $18 from $16 at Mizuho
PremiumThe Fly
Atara Biotherapeutics price target raised to $18 from $16 at Mizuho
8d ago
ATRA
Atara Biotherapeutics price target raised to $140 from $131 at Mizuho
PremiumThe Fly
Atara Biotherapeutics price target raised to $140 from $131 at Mizuho
8d ago
ATRA
Potential FDA Approval of Atara’s Tab-cel Therapy: A Game-Changer for Future Growth and CAR T Program Revitalization
PremiumRatings
Potential FDA Approval of Atara’s Tab-cel Therapy: A Game-Changer for Future Growth and CAR T Program Revitalization
15d ago
ATRA
Atara Biotherapeutics reports Q3 EPS (32c), consensus (67c)
PremiumThe Fly
Atara Biotherapeutics reports Q3 EPS (32c), consensus (67c)
16d ago
ATRA
Atara Biotherapeutics reduces workforce by 29%
PremiumThe FlyAtara Biotherapeutics reduces workforce by 29%
16d ago
ATRA
Pierre Fabre announces transfer of BLA for tabelecleucel from Atara Biotherapeutics
Premium
The Fly
Pierre Fabre announces transfer of BLA for tabelecleucel from Atara Biotherapeutics
25d ago
ATRA
Atara Biotherapeutics Announces Significant Workforce Reduction
Premium
Company Announcements
Atara Biotherapeutics Announces Significant Workforce Reduction
2M ago
8K
ATRA
Atara Biotherapeutics Reduces Board Size, Appoints New Chair
PremiumCompany Announcements
Atara Biotherapeutics Reduces Board Size, Appoints New Chair
3M ago
8K
ATRA
Atara Biotherapeutics: Hold Rating Amid Tab-cel Developments and Financial Uncertainty
PremiumRatings
Atara Biotherapeutics: Hold Rating Amid Tab-cel Developments and Financial Uncertainty
3M ago
ATRA
Atara Biotherapeutics reports Q2 EPS 19c vs. ($3.10) last year
PremiumThe Fly
Atara Biotherapeutics reports Q2 EPS 19c vs. ($3.10) last year
4M ago
ATRA
ATRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ATRA Upcoming Earnings Report: What to Expect?
4M ago
ATRA
Atara Biotherapeutics announces FDA acceptance of tabelecleucel BLA
PremiumThe FlyAtara Biotherapeutics announces FDA acceptance of tabelecleucel BLA
4M ago
ATRA
Atara Biotherapeutics announces FDA acceptance of BLA for tabelecleucel
Premium
The Fly
Atara Biotherapeutics announces FDA acceptance of BLA for tabelecleucel
4M ago
ATRA
Atara Biotherapeutics: Strategic Advancements and Financial Stability Support Buy Rating
Premium
Ratings
Atara Biotherapeutics: Strategic Advancements and Financial Stability Support Buy Rating
5M ago
ATRA
Atara Biotherapeutics Resubmits BLA for Tab-cel to FDA
PremiumCompany Announcements
Atara Biotherapeutics Resubmits BLA for Tab-cel to FDA
5M ago
8K
ATRA
Atara Biotherapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Atara Biotherapeutics Holds Annual Stockholders Meeting
6M ago
8K
ATRA
Atara Biotherapeutics appoints Huang, Subramanian to board of directors
PremiumThe Fly
Atara Biotherapeutics appoints Huang, Subramanian to board of directors
6M ago
ATRA
Atara Biotherapeutics Reports Strong Q1 2025 Results
PremiumCompany Announcements
Atara Biotherapeutics Reports Strong Q1 2025 Results
7M ago
ATRA
Atara Biotherapeutics Announces $16M Stock Offering
PremiumCompany AnnouncementsAtara Biotherapeutics Announces $16M Stock Offering
7M ago
8K
ATRA
Buy Rating for Atara Biotherapeutics: Strategic Focus and Financial Positioning Ahead of Key FDA Meeting
Premium
Ratings
Buy Rating for Atara Biotherapeutics: Strategic Focus and Financial Positioning Ahead of Key FDA Meeting
7M ago
ATRA
Atara Biotherapeutics Appoints New Board Members Amid Restructuring
Premium
Company Announcements
Atara Biotherapeutics Appoints New Board Members Amid Restructuring
7M ago
8K
ATRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >